This activity will teach how to recognize the diagnostic approach to NTM-LD, including mycobacterial subspecies identification and evaluation of drug resistance and evaluate the efficacy, toxicity, and drug interactions of antibiotics used in the treatment of NTM-LD

To inform physicians on strategies for selecting adjuvant therapy in melanoma as well as use of systemic therapy in metastatic melanoma based on new treatment approvals of clinical interest, with practice-changing implications.

Identify benefits of neoadjuvant therapy in patients with borderline resectable pancreatic cancer

Assess optimal time to initiate treatment for FL in order to delay disease progression and maintain patient quality of life

This activity is intended for oncology specialists who treat pediatric patients with high-risk neuroblastoma, such as physicians, physician assistants and social workers.

At the conclusion of this webcast, participants should be able to adopt diagnostic and prognostic methods and guidelines to stage and grade (low vs high), Summarize the benefits and challenges of available treatment options for low-grade and Examine latest clinical data on emerging strategies, such as chemoablation, for low-grade UTUC

Formulate management plans and review emerging strategies for adverse events associated with PARP inhibitors in the frontline, maintenance setting.

Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE), is a common and serious medical condition associated with significant morbidity, mortality, and cost.